Celldex Therapeutics Market Sentiment

Celldex Therapeutics Inc

CLDXNASDAQ

Trade with Public

$30.41

0.742.49%

Ult. Agg.: Oct 20, 1:59 PM

$29.95

0.280.94%

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Celldex Therapeutics Market Sentiment

Market sentiment signals for Celldex Therapeutics (CLDX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 16.6% short float

Options Flow▼ 2.23 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

16 analysts

Options Flow (P/C)

2.23

More puts — Bearish

116 calls · 259 puts

Avg Consensus PT

$61

+98.9%

Highest Price Target

$100

+228.8%

Guggenheim

Lowest Price Target

$34

+11.8%

Goldman Sachs

Short Interest

16.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 2, 2026	HC Wainwright & Co.	Joseph Pantginis—	+110.5%	$64 → $64	Maintained	Buy
Sep 23, 2026	Leerink Partners	Thomas Smith—	+189.4%	$70 → $88	Maintained	Outperform
Sep 23, 2026	Morgan Stanley	Judah Frommer—	+87.4%	$50 → $57	Maintained	Overweight
Sep 22, 2026	HC Wainwright & Co.	Joseph Pantginis—	+110.5%	$42 → $64	Maintained	Buy
Sep 22, 2026	Cantor Fitzgerald	Kristen Kluska—	+136.8%	$61 → $72	Maintained	Overweight
Sep 10, 2026	Morgan Stanley	Judah Frommer—	+64.4%	$46 → $50	Maintained	Overweight
Aug 7, 2026	Morgan Stanley	Judah Frommer—	+51.3%	$40 → $46	Maintained	Overweight
Aug 7, 2026	Barclays	Etzer Darout—	+74.3%	$48 → $53	Maintained	Overweight
Jul 29, 2026	Wells Fargo	Derek Archila—	+136.8%	$48 → $72	Maintained	Overweight
Jul 22, 2026	Wells Fargo	Derek Archila—	+57.8%	$54 → $48	Maintained	Overweight
Jul 22, 2026	Morgan Stanley	Judah Frommer—	+31.5%	$44 → $40	Maintained	Overweight
Jul 22, 2026	Cantor Fitzgerald	Kristen Kluska—	+100.6%	$67 → $61	Maintained	Overweight
Jul 22, 2026	Canaccord Genuity	Edward Nash—	+97.3%	$62 → $60	Maintained	Buy
Jul 20, 2026	Guggenheim	Yatin Suneja—	+228.8%	$90 → $100	Maintained	Buy
Jun 15, 2026	HC Wainwright & Co.	Joseph Pantginis—	+38.1%	$42 → $42	Maintained	Buy
Jun 10, 2026	UBS	David Dai—	+48.0%	$38 → $45	Maintained	Buy
May 13, 2026	Wells Fargo	Derek Archila—	+77.6%	$38 → $54	Maintained	Overweight
May 8, 2026	Barclays	Etzer Darout—	+57.8%	$45 → $48	Maintained	Overweight
Apr 20, 2026	Barclays	Etzer Darout—	+48.0%	$24 → $45	Upgrade	Underweight→Overweight
Mar 2, 2026	Goldman Sachs	Richard Law—	+11.8%	$30 → $34	Maintained	Neutral
Feb 26, 2026	Stifel	Alex Thompson—	+123.6%	$58 → $68	Maintained	Buy
Dec 17, 2025	Barclays	Etzer Darout—	-21.1%	$21 → $24	Maintained	Underweight
Nov 11, 2025	Barclays	Etzer Darout—	-30.9%	$25 → $21	Maintained	Underweight
Oct 21, 2025	Mizuho	Joseph Catanzaro—	+57.8%	$48	Initiate	Outperform
Oct 13, 2025	Barclays	Etzer Darout—	-17.8%	$25	Initiate	Underweight